Biktarvy, formally known as bictegravir, includes a potent single-tablet regimen for controlling HIV infection. This medication combines three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It works by inhibiting the HIV's ability to multiply within the body, significantly decreasing the viral burden. For many indivi